Allegion (ALLE)
(Delayed Data from NYSE)
$145.61 USD
-0.28 (-0.19%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $145.63 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$145.61 USD
-0.28 (-0.19%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $145.63 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
Johnson Controls (JCI) Q3 Earnings In Line, Revenues Rise Y/Y
by Zacks Equity Research
Johnson Controls' (JCI) fiscal Q3 results benefit from strength in the HVAC & Controls and Fire & Security businesses.
Xylem (XYL) Q2 Earnings & Revenues Top Estimates, '23 View Up
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from strong commercial and operational execution and contribution from the Evoqua acquisition. Following strong performance, the company raises its 2023 guidance.
Zebra Technologies (ZBRA) Q2 Earnings Beat, '23 View Bearish
by Zacks Equity Research
Despite surpassing earnings estimates, Zebra Technologies' (ZBRA) Q2 results are hurt by lower demand and reduced consumer spending. As a result, the company provides a bleak outlook for Q3 and 2023.
Illinois Tool (ITW) Beats on Q2 Earnings, Raises '23 EPS View
by Zacks Equity Research
Illinois Tool's (ITW) Q2 results benefit from organic sales growth. Anticipating stable underlying demand for the rest of 2023, the company improves its earnings guidance for 2023.
Allegion (ALLE) Beats on Q2 Earnings, Raises 2023 EPS View
by Zacks Equity Research
Allegion's (ALLE) second-quarter results benefit from robust price realization and strong growth in the electronics end market. The company raised its earnings guidance for 2023.
Allegion (ALLE) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Allegion (ALLE) delivered earnings and revenue surprises of 4.14% and 1.57%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Increasing costs and expenses, as well as forex woes, are likely to have hurt Xylem's (XYL) Q2 performance.
What's in the Offing for Illinois Tool (ITW) in Q2 Earnings?
by Zacks Equity Research
Strength in capital equipment, industrial and oil and gas businesses is expected to have driven Illinois Tool's (ITW) Q2 performance.
Will Low-Demand Dampen Stanley Black's (SWK) Q2 Earnings?
by Zacks Equity Research
Stanley Black's (SWK) Q2 performance is likely to have been hurt by a low-demand environment and weak industrial markets.
Is a Surprise Coming for Allegion (ALLE) This Earnings Season?
by Zacks Equity Research
Allegion (ALLE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Zebra Technologies (ZBRA) in Q2 Earnings?
by Zacks Equity Research
Large customer order deferrals in the mobile computing business within the EVM segment are likely to hurt Zebra Technologies' (ZBRA) second-quarter 2023 performance.
Will Allegion (ALLE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Allegion (ALLE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Strength in Process Segment to Aid Graco's (GGG) Q2 Earnings
by Zacks Equity Research
Graco's (GGG) Q2 earnings is likely to have benefited from robust project activity in lubrication, environmental and process pumps within the Process unit, partly offset by supply-chain woes.
What's in the Offing for Carlisle (CSL) in Q2 Earnings?
by Zacks Equity Research
Carlisle's (CSL) Q2 earnings are likely to have benefited from growing demand in the medical market and commercial aerospace business and favorable pricing policies.
What's in the Offing for Encore Wire (WIRE) in Q2 Earnings?
by Zacks Equity Research
Encore Wire's (WIRE) Q2 performance is likely to have been hurt by softness in copper wire unit volumes. An increase in aluminum spreads is likely to have partly offset this adversity.
Can Honeywell (HON) Retain Beat Streak This Earnings Season?
by Zacks Equity Research
Honeywell's (HON) Q2 performance is likely to have benefited primarily from strength in the Aerospace market and improvement in supply chains.
A. O. Smith (AOS) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Robust demand for commercial and residential boilers and water treatment products is likely to have aided A. O. Smith's (AOS) Q2 performance.
Allegion (ALLE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allegion (ALLE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Hubbell (HUBB) Retain Beat Streak This Earnings Season?
by Zacks Equity Research
Robust demand for products owing to grid modernization and electrification, lower raw material costs and improved productivity are likely to have driven Hubbell's (HUBB) Q2 performance.
Allegion (ALLE) Set to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Allegion's (ALLE) Q2 earnings are likely to have benefited from strengthening demand in end markets and effective pricing, partly offset by the rising cost of sales.
What's in the Cards for IDEX (IEX) This Earnings Season?
by Zacks Equity Research
Softness across pharma, biopharma and nutrition end markets within the material processing technology business is likely to have hurt IDEX's (IEX) Q2 performance.
Will Low COVID-Testing Volumes Mar Danaher's (DHR) Q2 Earnings?
by Zacks Equity Research
Lower demand for COVID-19 testing, vaccine and therapeutics is expected to have hurt Danaher's (DHR) Q2 performance. Rising cost of sales might have hurt the bottom line.
Will Inflationary Pressure Dampen 3M's (MMM) Q2 Earnings?
by Zacks Equity Research
Reduced consumer spending due to inflationary pressure and softness in disposable respirator demand are likely to have weighed on 3M's (MMM) Q2 earnings.
What's in the Offing for General Electric's (GE) Q2 Earnings?
by Zacks Equity Research
Supply-chain disruptions are likely to have hurt General Electric's (GE) Q2 earnings. However, the top line is expected to have benefited from an increase in revenues at the Aerospace unit.
Graco (GGG) Rides on End-Market Strength, Capacity Expansion
by Zacks Equity Research
Strong segmental performance, investments in product innovation and capacity expansion bode well for Graco (GGG).